Skip to main content
. 2017 Apr 13;17:265. doi: 10.1186/s12885-017-3261-1

Fig. 2.

Fig. 2

Primary endpoint: Change in adjuvant treatment recommendation between the first and second tumor board (after knowledge of the ODX recurrence score)